APA
REGN icon

American Portfolios Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

American Portfolios Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$205K Sell
297
-1
-0.3% -$629 0.01% 1009
2022
Q2 		$176K Sell
298
-223
-43% -$145K 0.01% 1105
2022
Q1 		$364K Buy
521
+203
+64% +$128K 0.01% 880
2021
Q4 		$201K Sell
318
-335
-51% -$206K 0.01% 1161
2021
Q3 		$395K Buy
653
+237
+57% +$147K 0.01% 816
2021
Q2 		$232K Sell
416
-2,300
-85% -$1.17M 0.01% 1043
2021
Q1 		$1.29M Buy
2,716
+2,234
+463% +$1.09M 0.06% 326
2020
Q4 		$233K Sell
482
-91
-16% -$49.1K 0.01% 835
2020
Q3 		$321K Sell
573
-884
-61% -$536K 0.02% 631
2020
Q2 		$909K Sell
1,457
-984
-40% -$559K 0.06% 293
2020
Q1 		$1.19M Buy
2,441
+2,300
+1,631% +$949K 0.1% 190
2019
Q4 		$52.9K Buy
141
+14
+11% +$4.71K ﹤0.01% 1318
2019
Q3 		$35.2K Sell
127
-7
-5% -$2.07K ﹤0.01% 1430
2019
Q2 		$41.9K Sell
134
-125
-48% -$41.6K ﹤0.01% 1348
2019
Q1 		$106K Buy
259
+151
+140% +$62.2K 0.01% 865
2018
Q4 		$40.3K Sell
108
-108
-50% -$39.5K 0.01% 1106
2018
Q3 		$87.3K Buy
216
+99
+85% +$37.7K 0.01% 885
2018
Q2 		$40.4K Hold
117
– – 0.01% 1160
2018
Q1 		$40.3K Buy
117
+27
+30% +$9.39K 0.01% 1118
2017
Q4 		$33.8K Buy
+90
New +$36.5K 0.01% 1141

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Portfolios Advisors's REGN Position: Q3 2022 in Review

American Portfolios Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 0.34% in Q3 2022, selling an estimated $629 and leaving 297 shares worth $205K. The position accounts for 0.01% of the portfolio, ranked #1009.

American Portfolios Advisors first reported a position in REGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.29M in Q1 2021. 1,081 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

  • American Portfolios Advisors held 297 shares of Regeneron Pharmaceuticals worth $205K as of Q3 2022.
  • American Portfolios Advisors sold 1 Regeneron Pharmaceuticals share in Q3 2022, an estimated $629.
  • Regeneron Pharmaceuticals made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1009 holding.
  • American Portfolios Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Regeneron Pharmaceuticals position peaked at $1.29M in Q1 2021.
  • 1,081 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.